Get started
BBB

BIO-GENE TECHNOLOGY LTD

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

BGT chart


Full chart

BGT upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪7.65 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−2.41 M‬ AUD
Revenue (FY)
‪18.32 K‬ AUD
Shares float
‪181.25 M‬
Beta (1Y)
−1.41

About BIO-GENE TECHNOLOGY LTD


Sector
Process Industries
CEO
Tim Grogan
Headquarters
Melbourne
Website
bio-gene.com.au
Founded
1995
ISIN
AU000000BGT8
FIGI
BBG00HXMHVF4
Bio-Gene Technology Ltd. engages in the research and development of the next generation of novel insecticides, addressing the problems of insecticide resistance and toxicity. Its novel platform technology is based on occurring beta-triketones, a type of chemistry that may offer solutions for insect management control in animal health and crop protection as well as in public health applications. The company was founded on November 8, 1995 and is headquartered in Melbourne, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

BGT news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BGT is 0.037 AUD — it has decreased by −2.63% in the past 24 hours. Watch BIO-GENE TECHNOLOGY LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange BIO-GENE TECHNOLOGY LTD stocks are traded under the ticker BGT.
BGT stock has fallen by −5.13% compared to the previous week, the month change is a −32.73% fall, over the last year BIO-GENE TECHNOLOGY LTD has showed a −40.32% decrease.
BGT reached its all-time high on Mar 2, 2022 with the price of 0.350 AUD, and its all-time low was 0.036 AUD and was reached on Nov 19, 2024. View more price dynamics on BGT chart.
See other stocks reaching their highest and lowest prices.
BGT stock is 2.70% volatile and has beta coefficient of −1.41. Track BIO-GENE TECHNOLOGY LTD stock price on the chart and check out the list of the most volatile stocks — is BIO-GENE TECHNOLOGY LTD there?
Today BIO-GENE TECHNOLOGY LTD has the market capitalization of ‪7.65 M‬, it has decreased by −10.00% over the last week.
Yes, you can track BIO-GENE TECHNOLOGY LTD financials in yearly and quarterly reports right on TradingView.
BIO-GENE TECHNOLOGY LTD is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
No, BGT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BGT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIO-GENE TECHNOLOGY LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIO-GENE TECHNOLOGY LTD technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIO-GENE TECHNOLOGY LTD stock shows the sell signal. See more of BIO-GENE TECHNOLOGY LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.